Company Quick10K Filing
Manhattan Associates
10-Q 2021-03-31 Filed 2021-04-29
10-K 2020-12-31 Filed 2021-02-05
10-Q 2020-09-30 Filed 2020-11-02
10-Q 2020-06-30 Filed 2020-07-27
10-Q 2020-03-31 Filed 2020-05-01
10-K 2019-12-31 Filed 2020-02-10
10-Q 2019-09-30 Filed 2019-10-25
10-Q 2019-06-30 Filed 2019-07-25
10-Q 2019-03-31 Filed 2019-04-25
10-K 2018-12-31 Filed 2019-02-08
10-Q 2018-09-30 Filed 2018-10-25
10-Q 2018-06-30 Filed 2018-07-26
10-Q 2018-03-31 Filed 2018-04-27
10-K 2017-12-31 Filed 2018-02-09
10-Q 2017-09-30 Filed 2017-10-30
10-Q 2017-06-30 Filed 2017-07-24
10-Q 2017-03-31 Filed 2017-04-24
10-K 2016-12-31 Filed 2017-02-03
10-Q 2016-09-30 Filed 2016-10-21
10-Q 2016-06-30 Filed 2016-07-22
10-Q 2016-03-31 Filed 2016-04-22
10-K 2015-12-31 Filed 2016-02-05
10-Q 2015-09-30 Filed 2015-10-26
10-Q 2015-06-30 Filed 2015-07-28
10-Q 2015-03-31 Filed 2015-04-28
10-K 2014-12-31 Filed 2015-02-05
10-Q 2014-09-30 Filed 2014-10-29
10-Q 2014-06-30 Filed 2014-07-29
10-Q 2014-03-31 Filed 2014-04-29
10-K 2013-12-31 Filed 2014-02-06
10-Q 2013-09-30 Filed 2013-10-31
10-Q 2013-06-30 Filed 2013-07-31
10-Q 2013-03-31 Filed 2013-04-30
10-K 2012-12-31 Filed 2013-02-22
10-Q 2012-09-30 Filed 2012-10-31
10-Q 2012-06-30 Filed 2012-08-06
10-Q 2012-03-31 Filed 2012-05-04
10-K 2011-12-31 Filed 2012-02-23
10-Q 2011-09-30 Filed 2011-10-28
10-Q 2011-06-30 Filed 2011-07-29
10-Q 2011-03-31 Filed 2011-04-29
10-K 2010-12-31 Filed 2011-02-23
10-Q 2010-09-30 Filed 2010-10-29
10-Q 2010-06-30 Filed 2010-08-02
10-Q 2010-03-31 Filed 2010-04-30
10-K 2009-12-31 Filed 2010-02-19
8-K 2020-10-22
8-K 2020-07-23
8-K 2020-05-14
8-K 2020-04-21
8-K 2020-03-30
8-K 2020-02-04
8-K 2019-10-22
8-K 2019-07-23
8-K 2019-05-14
8-K 2019-04-23
8-K 2019-02-05
8-K 2018-10-23
8-K 2018-10-23
8-K 2018-07-24
8-K 2018-05-17
8-K 2018-04-24
8-K 2018-02-06

Manhattan Associates Financials

MANH Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash10394929295999710199118124117911011169710010911810693111968977125126107799099105119114
Accounts Receivable5357565764736260686871678788878383929784939910084969792859993100107100108
Inventory
PP&E14147014141463151414641415166819202175212120661716156316151564131521
Assets268263260258262276262265269287298291289305318300300323338303294316297287285326315307292291307360372380
Accounts Payable988688107781281010121091011101210121113151415211418171721
Long-Term Debt
Liabilities97101989599106100101101111116113112120136122116132142128119129128139127132140159163151160214217229
Stockholders' Equity171161162163163170162163167177182178176184182179184190195175175187169148158194175148129140147145155152
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8886849194969597103108108114128126130134139142141150155152148143154153144131142142144148154162
Cost of Revenue272827383941434344454948555459585958466563624862626359585961677274
Gross Profit6158575454555254596359667372727580849585929110082929085738381818388
R&D11111012111111111111111212121314131413151313131414151517181818212223
SG&A22202123222020212020212325222823242526252421262423222526272427303128
Tax6566987610128111213101416161316202016131819186997779
Net Income12151111141412131720171921222023262826273333302831332523282826212127
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating171513211724201433231933401528413640194238611144475135353740
Cash Investing-0-10-2-3-2-2-2-2-2-2-6-1-4-1-6-2-041-1-12043-15-11-3-8
Cash Financing-25-14-14-14-12-23-14-12-11-14-26-15-24-29-24-25-24-53-35-25-50-57-25-0-50-56-21-30-20-36